MLS® and COVID-19: a new success in treating interstitial pneumonia

02 October 2020 - Research -
Share

A new case confirms the effectiveness of MLS® as supporting therapy for treating pneumonia caused by COVID-19.

An obese patient with interstitial pneumonia who was treated for 4 days with MLS® Laser Therapy reported a concrete and progressive improvement in her critical parameters such as oxygen saturation, which increased to 97-99%, radiographic assessment of the pulmonary oedema (RALE) which went from 8 to 2, Brescia-COVID Respiratory Severity Scale (a score which assesses the gravity of the pneumonia and is used for patient progress management) which went from 4 to 0 and SMART-COP (a tool which monitors the seriousness of the pneumonia and predicts the need for intervening such as with a move to intensive care, etc.) which dropped from 5 to 1. Interleukin-6, ferritin and C-reactive protein also recorded a significant contraction.

The data were reported by the study “Adjunct low level laser therapy (LLLT) in a morbidly obese patient with severe COVID-19 pneumonia: A case report” whose conclusions indicate that use of MLS® Laser Therapy for the case in question recorded a significant improvement of the respiratory indexes, radiological results and inflammatory markers in just a few days.

A result which suggests that ASA’s therapy can safely be combined with conventional treatment for patients suffering from severe COVID-19 and morbid obesity.

Max 980px
Blog - obese patient with severe COVID-19 pneumonia assessment

You might also be interested in ...

See all articles

press - 01/09/2020
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
MLS Laser Therapy for the treatment of COVID19 pneumonia
blog - 24/08/2020
A very recent case report concerning the use of MLS® Laser Therapy supporting a patient suffering from severe pneumonia caused by Covid-19 reported a significant improvement in some basic parameters...
MLS Laser Therapy in a morbidly obese patient with severe COVID-19 pneumonia
Research
S.A. Sigman, S. Mokmeli, M.A. Vetrici Canadian Journal of Respiratory Therapy, 56:52–56, 2020
ASAlaser @ Pecs - Hungary
News - 13/11/2024
Thanks to the collaboration with the local distributor Procardia & Meddevice, present with its own stand, the company staff were able to meet long-standing customers and, at the same time, to...
Hilterapia and nerve function
Blog - 04/11/2024
A recent study conducted by Alayat et al. (2024) is the first to examine the effects of Hilterapia® - pulsed Nd:YAG laser source (1064nm) - on skin temperature and nerve function in healthy...
MLS Laser Therapy Speech in Brasov, Romania
News - 30/10/2024
MLS® Laser Therapy and some of its flagship devices could not miss out on attending the “National Congress of Physical Medicine and Rehabilitation” in Brasov (Romania, 16-19 October).